Global Longlife Hospital & Research Ltd. operates as a multi-specialty tertiary care hospital. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-05-04. The firm's medical services include oncology, ophthalmology, allergy & immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes & endocrinology, GI medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include CVTS, joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery and ear, nose and throat (ENT). Its radiology services include mammography, CT scan, X-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
23 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.